Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (trading symbol: NAOV) on December 11, 2024. The filing reports a specific corporate event rather than a standard financial reporting period. The registrant is incorporated in Delaware and maintains its principal executive offices in Tyler, Texas.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves to announce a contractual event and does not contain audited or unaudited financial statements for the period.
Material Changes
The primary material event reported is the renewal of a distribution agreement with Ultra Pain Products Inc., announced via press release on December 11, 2024. No other material changes to financial position or operations are detailed in this specific filing.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or a discussion of specific risks and contingencies beyond the context of the distribution agreement renewal. The press release detailing the agreement is attached as Exhibit 99.1 but its specific terms are not summarized in the body of this 8-K.
Investor Verification Checklist
- Verify the specific terms and duration of the renewed distribution agreement with Ultra Pain Products Inc. by reviewing Exhibit 99.1 (Press Release).
- Confirm the impact of this renewal on future revenue streams, as no financial projections are included in this filing.
- Check recent stock price movements for NAOV following the December 11, 2024 announcement.
- Review the company's most recent 10-Q or 10-K for baseline financial metrics, as this 8-K contains none.